ASX - By Stock
|
VLA |
Re:
Investor Presentation
|
|
TheDerivative
|
3 |
1.8K |
4 |
09/01/18 |
09/01/18 |
ASX - By Stock
|
3
|
1.8K
|
4
|
|
ASX - By Stock
|
VLA |
Re:
Ann: $29.6m Equity Placement to Lepu Medical Group of China
|
|
TheDerivative
|
80 |
32K |
2 |
05/01/18 |
05/01/18 |
ASX - By Stock
|
80
|
32K
|
2
|
|
ASX - By Stock
|
VLA |
Re:
Ann: $29.6m Equity Placement to Lepu Medical Group of China
|
|
TheDerivative
|
80 |
32K |
6 |
05/01/18 |
05/01/18 |
ASX - By Stock
|
80
|
32K
|
6
|
|
ASX - By Stock
|
VLA |
Re:
Ann: Trading Halt
|
|
TheDerivative
|
78 |
33K |
2 |
05/01/18 |
05/01/18 |
ASX - By Stock
|
78
|
33K
|
2
|
|
ASX - By Stock
|
VLA |
Re:
Chaiman's Letter to Shareholders
|
|
TheDerivative
|
27 |
11K |
6 |
30/11/17 |
30/11/17 |
ASX - By Stock
|
27
|
11K
|
6
|
|
ASX - By Stock
|
VLA |
Re:
Chaiman's Letter to Shareholders
|
|
TheDerivative
|
27 |
11K |
2 |
29/11/17 |
29/11/17 |
ASX - By Stock
|
27
|
11K
|
2
|
|
ASX - By Stock
|
VLA |
Re:
Ann: New Data at SITC Meeting. Further Studies Announced
|
|
TheDerivative
|
93 |
27K |
9 |
18/11/17 |
18/11/17 |
ASX - By Stock
|
93
|
27K
|
9
|
|
ASX - By Stock
|
VLA |
Re:
Ann: New Data at SITC Meeting. Further Studies Announced
|
|
TheDerivative
|
93 |
27K |
6 |
16/11/17 |
16/11/17 |
ASX - By Stock
|
93
|
27K
|
6
|
|
ASX - By Stock
|
VLA |
Re:
SMH Article - Stop melanoma
|
|
TheDerivative
|
13 |
3.2K |
3 |
11/09/17 |
11/09/17 |
ASX - By Stock
|
13
|
3.2K
|
3
|
|
ASX - By Stock
|
VLA |
Re:
Gilead buys Kite Pharma for $11.9 BN
|
|
TheDerivative
|
31 |
10K |
4 |
06/09/17 |
06/09/17 |
ASX - By Stock
|
31
|
10K
|
4
|
|
ASX - By Stock
|
VLA |
Re:
Gilead buys Kite Pharma for $11.9 BN
|
|
TheDerivative
|
31 |
10K |
0 |
01/09/17 |
01/09/17 |
ASX - By Stock
|
31
|
10K
|
0
|
|
ASX - By Stock
|
VLA |
Gilead buys Kite Pharma for $11.9 BN
|
|
TheDerivative
|
31 |
10K |
8 |
31/08/17 |
31/08/17 |
ASX - By Stock
|
31
|
10K
|
8
|
|
ASX - By Stock
|
VLA |
Re:
Bioshares Biotech Summit
|
|
TheDerivative
|
18 |
5.0K |
6 |
31/07/17 |
31/07/17 |
ASX - By Stock
|
18
|
5.0K
|
6
|
|
ASX - By Stock
|
VLA |
Re:
Bioshares Biotech Summit
|
|
TheDerivative
|
18 |
5.0K |
2 |
31/07/17 |
31/07/17 |
ASX - By Stock
|
18
|
5.0K
|
2
|
|
ASX - By Stock
|
VLA |
Re:
Can this get any worse???
|
|
TheDerivative
|
53 |
21K |
3 |
26/06/17 |
26/06/17 |
ASX - By Stock
|
53
|
21K
|
3
|
|
ASX - By Stock
|
VLA |
Re:
ASCO 2017
|
|
TheDerivative
|
69 |
27K |
5 |
02/06/17 |
02/06/17 |
ASX - By Stock
|
69
|
27K
|
5
|
|
ASX - By Stock
|
VLA |
Re:
ASCO 2017
|
|
TheDerivative
|
69 |
27K |
2 |
20/05/17 |
20/05/17 |
ASX - By Stock
|
69
|
27K
|
2
|
|
ASX - By Stock
|
VLA |
Re:
ASCO 2017
|
|
TheDerivative
|
69 |
27K |
0 |
11/05/17 |
11/05/17 |
ASX - By Stock
|
69
|
27K
|
0
|
|
ASX - By Stock
|
VLA |
Re:
ASCO 2017
|
|
TheDerivative
|
69 |
27K |
0 |
11/05/17 |
11/05/17 |
ASX - By Stock
|
69
|
27K
|
0
|
|
ASX - By Stock
|
VLA |
Re:
ASCO 2017
|
|
TheDerivative
|
69 |
27K |
0 |
11/05/17 |
11/05/17 |
ASX - By Stock
|
69
|
27K
|
0
|
|
ASX - By Stock
|
VLA |
Re:
ASCO 2017
|
|
TheDerivative
|
69 |
27K |
2 |
11/05/17 |
11/05/17 |
ASX - By Stock
|
69
|
27K
|
2
|
|
ASX - By Stock
|
VLA |
Re:
Think before you act
|
|
TheDerivative
|
76 |
21K |
7 |
05/04/17 |
05/04/17 |
ASX - By Stock
|
76
|
21K
|
7
|
|
ASX - By Stock
|
VLA |
Re:
Interesting Articles
|
|
TheDerivative
|
2 |
1.2K |
4 |
11/01/17 |
11/01/17 |
ASX - By Stock
|
2
|
1.2K
|
4
|
|
ASX - By Stock
|
VLA |
Re:
Phase 2, Phase 3, Phase 4
|
|
TheDerivative
|
30 |
10K |
1 |
19/12/16 |
19/12/16 |
ASX - By Stock
|
30
|
10K
|
1
|
|
ASX - By Stock
|
VLA |
Phase 2, Phase 3, Phase 4
|
|
TheDerivative
|
30 |
10K |
3 |
16/12/16 |
16/12/16 |
ASX - By Stock
|
30
|
10K
|
3
|
|
ASX - By Stock
|
VLA |
Re:
Voting - Resolution 8
|
|
TheDerivative
|
14 |
3.8K |
0 |
24/10/16 |
24/10/16 |
ASX - By Stock
|
14
|
3.8K
|
0
|
|
ASX - By Stock
|
VLA |
Re:
vla
|
|
TheDerivative
|
118 |
38K |
1 |
13/10/16 |
13/10/16 |
ASX - By Stock
|
118
|
38K
|
1
|
|
ASX - By Stock
|
VLA |
Re:
vla
|
|
TheDerivative
|
118 |
38K |
0 |
13/10/16 |
13/10/16 |
ASX - By Stock
|
118
|
38K
|
0
|
|
ASX - By Stock
|
VLA |
Re:
Roth Update on CAVATAK YERVOY Data presented at ESMO Congress
|
|
TheDerivative
|
30 |
9.0K |
2 |
12/10/16 |
12/10/16 |
ASX - By Stock
|
30
|
9.0K
|
2
|
|
ASX - By Stock
|
VLA |
Re:
Roth Update on CAVATAK YERVOY Data presented at ESMO Congress
|
|
TheDerivative
|
30 |
9.0K |
1 |
12/10/16 |
12/10/16 |
ASX - By Stock
|
30
|
9.0K
|
1
|
|
ASX - By Stock
|
VLA |
Re:
Roth Update on CAVATAK YERVOY Data presented at ESMO Congress
|
|
TheDerivative
|
30 |
9.0K |
8 |
11/10/16 |
11/10/16 |
ASX - By Stock
|
30
|
9.0K
|
8
|
|
ASX - By Stock
|
VLA |
Re:
Roth Update on CAVATAK YERVOY Data presented at ESMO Congress
|
|
TheDerivative
|
30 |
9.0K |
7 |
11/10/16 |
11/10/16 |
ASX - By Stock
|
30
|
9.0K
|
7
|
|
ASX - By Stock
|
VLA |
Re:
How Merck Caused Bristol-Myers' Plunge
|
|
TheDerivative
|
15 |
3.3K |
2 |
11/10/16 |
11/10/16 |
ASX - By Stock
|
15
|
3.3K
|
2
|
|
ASX - By Stock
|
VLA |
Re:
Ann: VLA update on CAVATAK KEYTRUDA Combination trials - ESMO-VLA.AX
|
|
TheDerivative
|
32 |
8.6K |
0 |
10/10/16 |
10/10/16 |
ASX - By Stock
|
32
|
8.6K
|
0
|
|
ASX - By Stock
|
VLA |
Re:
Ann: VLA update on CAVATAK KEYTRUDA Combination trials - ESMO-VLA.AX
|
|
TheDerivative
|
32 |
8.6K |
7 |
10/10/16 |
10/10/16 |
ASX - By Stock
|
32
|
8.6K
|
7
|
|
ASX - By Stock
|
VLA |
Re:
Up coming news
|
|
TheDerivative
|
71 |
21K |
2 |
04/10/16 |
04/10/16 |
ASX - By Stock
|
71
|
21K
|
2
|
|
ASX - By Stock
|
VLA |
Re:
Ann: VLA to Present CAVATAK Clinical Data at Upcoming Conferences-VLA.AX
|
|
TheDerivative
|
31 |
9.2K |
0 |
23/09/16 |
23/09/16 |
ASX - By Stock
|
31
|
9.2K
|
0
|
|
ASX - By Stock
|
VLA |
Re:
Fight Club
|
|
TheDerivative
|
14 |
5.1K |
1 |
20/09/16 |
20/09/16 |
ASX - By Stock
|
14
|
5.1K
|
1
|
|
ASX - By Stock
|
VLA |
Re:
Fight Club
|
|
TheDerivative
|
14 |
5.1K |
0 |
20/09/16 |
20/09/16 |
ASX - By Stock
|
14
|
5.1K
|
0
|
|
ASX - By Stock
|
VLA |
Re:
Viralytics on The Business ABC
|
|
TheDerivative
|
54 |
13K |
1 |
04/06/16 |
04/06/16 |
ASX - By Stock
|
54
|
13K
|
1
|
|
ASX - By Stock
|
VLA |
Re:
VLA - something going on ?
|
|
TheDerivative
|
39 |
14K |
4 |
25/05/16 |
25/05/16 |
ASX - By Stock
|
39
|
14K
|
4
|
|
ASX - By Stock
|
TYX |
Re:
Ann: Drilling Extends Golf Bore Strike Length-TYX.AX
|
|
TheDerivative
|
13 |
5.5K |
4 |
06/05/16 |
06/05/16 |
ASX - By Stock
|
13
|
5.5K
|
4
|
|
ASX - By Stock
|
VLA |
Re:
Roth Report
|
|
TheDerivative
|
58 |
22K |
0 |
28/04/16 |
28/04/16 |
ASX - By Stock
|
58
|
22K
|
0
|
|
ASX - By Stock
|
VLA |
Re:
Todays Volume . Sorry !
|
|
TheDerivative
|
33 |
8.3K |
0 |
03/03/16 |
03/03/16 |
ASX - By Stock
|
33
|
8.3K
|
0
|
|
ASX - By Stock
|
VLA |
Opdivo, Earnings and Combination Therapies
|
|
TheDerivative
|
1 |
2.8K |
8 |
19/02/16 |
19/02/16 |
ASX - By Stock
|
1
|
2.8K
|
8
|
|
ASX - By Stock
|
VLA |
Re:
Orbimed
|
|
TheDerivative
|
41 |
11K |
8 |
16/12/15 |
16/12/15 |
ASX - By Stock
|
41
|
11K
|
8
|
|
ASX - By Stock
|
VLA |
Re:
Orbimed
|
|
TheDerivative
|
41 |
11K |
13 |
16/12/15 |
16/12/15 |
ASX - By Stock
|
41
|
11K
|
13
|
|
ASX - By Stock
|
VLA |
Re:
Orbimed
|
|
TheDerivative
|
41 |
11K |
2 |
15/12/15 |
15/12/15 |
ASX - By Stock
|
41
|
11K
|
2
|
|
ASX - By Stock
|
VLA |
Re:
$30m expected raising
|
|
TheDerivative
|
39 |
9.9K |
5 |
14/12/15 |
14/12/15 |
ASX - By Stock
|
39
|
9.9K
|
5
|
|
ASX - By Stock
|
VLA |
Re:
Ann: Director and Management Options for Viralytics Leadership
|
|
TheDerivative
|
31 |
7.2K |
1 |
18/09/15 |
18/09/15 |
ASX - By Stock
|
31
|
7.2K
|
1
|
|